Novo Holdings A/S - Q3 2023 holdings

$1.35 Billion is the total value of Novo Holdings A/S's 40 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 12.2% .

 Value Shares↓ Weighting
NewBROOKFIELD CORPcl a ltd vt sh$121,334,7923,880,230
+100.0%
8.97%
ASML  ASML HOLDING N V$116,413,402
-18.8%
197,7600.0%8.60%
-22.3%
CRM  SALESFORCE.COM, INC.$107,574,790
-4.0%
530,5000.0%7.95%
-8.2%
CORT  CORCEPT THERAPEUTICS INC$92,044,178
+22.5%
3,377,7680.0%6.80%
+17.1%
 LANZATECH GLOBAL INC$73,855,326
-31.6%
15,814,8450.0%5.46%
-34.6%
CABO BuyCABLE ONE INC$72,893,623
+17.9%
118,403
+25.8%
5.39%
+12.7%
TSM  TAIWAN SEMICONDUCTOR MFG LTDsponsored ads$61,766,782
-13.9%
710,7800.0%4.56%
-17.7%
 DISC MEDICINE, INC.$51,244,485
+5.8%
1,090,7720.0%3.79%
+1.2%
MIRM SellMIRUM PHARMACEUTICALS INC$47,400,000
+8.8%
1,500,000
-10.9%
3.50%
+4.0%
BABA  ALIBABA GROUP HLDG LTDsponsored ads$43,441,734
+4.1%
500,8270.0%3.21%
-0.5%
PCVX  VAXCYTE INC$43,078,100
+2.1%
845,0000.0%3.18%
-2.4%
BuyARCELLX, INC.$38,571,000
+22.0%
1,075,000
+7.5%
2.85%
+16.7%
AAPL  APPLE INC$37,916,167
-11.7%
221,4600.0%2.80%
-15.6%
BMRN  BIOMARIN PHARMACEUTICAL INC$35,392,000
+2.1%
400,0000.0%2.62%
-2.4%
EWTX  EDGEWISE THERAPEUTICS INC$34,790,858
-26.1%
6,071,7030.0%2.57%
-29.3%
SGEN  SEAGEN INC.$33,941,030
+10.2%
159,9860.0%2.51%
+5.4%
INSM  INSMED INC$33,817,426
+19.7%
1,339,3040.0%2.50%
+14.4%
CRNX  CRINETICS PHARMACEUTICALS IN$32,714,000
+65.0%
1,100,0000.0%2.42%
+57.8%
PHVS  PHARVARIS N V$27,743,013
+37.8%
1,329,3250.0%2.05%
+31.8%
BPMC BuyBLUEPRINT MEDICINES CORP$26,365,500
-7.0%
525,000
+17.0%
1.95%
-11.1%
FOLD  AMICUS THERAPEUTICS INC$25,486,144
-3.2%
2,095,9000.0%1.88%
-7.4%
RPHM  RENEO PHARMACEUTICALS INC$25,344,169
+16.0%
3,330,3770.0%1.87%
+11.0%
CBAY SellCYMABAY THERAPEUTICS INC$23,356,828
+6.7%
1,566,521
-21.7%
1.73%
+2.0%
ALNY  ALNYLAM PHARMACEUTICALS INC$20,965,629
-6.8%
118,3830.0%1.55%
-10.8%
NewBROOKFIELD ASSET MANAGMT LTD$20,911,081627,207
+100.0%
1.54%
RCKT BuyROCKET PHARMACEUTICALS INC$20,510,490
+12.2%
1,001,000
+8.8%
1.52%
+7.3%
FDMT Buy4D MOLECULAR THERAPEUTICS IN$15,276,000
-15.5%
1,200,000
+20.0%
1.13%
-19.1%
SPRB  SPRUCE BIOSCIENCES INC$15,192,479
+5.1%
6,722,3360.0%1.12%
+0.5%
INSP BuyINSPIRE MED SYS INC$11,906,400
+12.8%
60,000
+84.6%
0.88%
+8.0%
BuyIO BIOTECH INC$8,103,364
+26.4%
5,747,067
+75.3%
0.60%
+21.0%
 RALLYBIO CORP$7,373,557
-40.5%
2,187,9990.0%0.54%
-43.1%
ABCL  ABCELLERA BIOLOGICS INC$5,183,809
-28.8%
1,126,9150.0%0.38%
-32.0%
SILK  SILK RD MED INC$5,004,921
-53.9%
333,8840.0%0.37%
-55.8%
TMCI  TREACE MED CONCEPTS INC$4,719,600
-48.7%
360,0000.0%0.35%
-51.0%
LVTX  LAVA THERAPEUTICS NV$3,528,000
-27.6%
2,400,0000.0%0.26%
-30.6%
MQ  MARQETA INC$2,640,517
+22.8%
441,5580.0%0.20%
+17.5%
CYT SellCYTEIR THERAPEUTICS INC$1,920,916
-79.8%
676,379
-81.5%
0.14%
-80.7%
GLTO  GALECTO INC$1,798,410
-71.4%
2,497,7910.0%0.13%
-72.6%
KNTE  KINNATE BIOPHARMA INC$1,141,990
-53.8%
815,7070.0%0.08%
-56.0%
SPRO  SPERO THERAPEUTICS INC$567,371
-16.6%
468,9020.0%0.04%
-20.8%
GRTX ExitGALERA THERAPEUTICS INC$0-2,100,000
-100.0%
-0.51%
VERV ExitVERVE THERAPEUTICS INC$0-500,000
-100.0%
-0.72%
BAM ExitBROOKFIELD ASSET MGMT INCcl a ltd vt sh$0-627,207
-100.0%
-1.58%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VANGUARD INDEX FDS41Q3 202264.7%
INOGEN INC34Q2 202268.8%
VANGUARD INTL EQUITY INDEX F29Q4 201637.6%
AMICUS THERAPEUTICS INC22Q3 20234.1%
AKEBIA THERAPEUTICS INC21Q3 20204.8%
VERONA PHARMA PLC21Q2 20221.9%
CORVUS PHARMACEUTICALS INC20Q4 20207.1%
INSPIRE MED SYS INC20Q3 20231.8%
CABLE ONE INC19Q3 20239.7%
FLEXION THERAPEUTICS INC19Q3 20214.7%

View Novo Holdings A/S's complete holdings history.

Latest significant ownerships (13-D/G)
Novo Holdings A/S Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cyteir Therapeutics, Inc.August 03, 20231,547,1364.4%
Disc Medicine, Inc.June 28, 20231,090,7724.8%
Galera Therapeutics, Inc.June 28, 20232,100,0004.9%
VectivBio Holding AGSold outMay 26, 202300.0%
LanzaTech Global, Inc.February 17, 202315,814,8458.1%
Bolt Biotherapeutics, Inc.Sold outJanuary 04, 202300.0%
Arcellx, Inc.December 12, 20221,750,0004.0%
MINERVA SURGICAL INCNovember 03, 20221,322,4734.5%
Milestone Pharmaceuticals Inc.October 24, 20221,378,5384.6%
Galecto, Inc.September 30, 20222,497,7919.8%

View Novo Holdings A/S's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-25
SC 13D/A2024-03-25
42024-03-20
SC 13D/A2024-03-20
1442024-03-18
42024-03-18
SC 13D/A2024-03-18
1442024-03-14
SC 13D/A2024-03-07
42024-02-15

View Novo Holdings A/S's complete filings history.

Compare quarters

Export Novo Holdings A/S's holdings